LONP1
LONP1 is an ATP-dependent serine protease of the mitochondrial matrix that degrades misfolded, unassembled or oxidatively damaged proteins. It is also known as LonHS, hLON, PIM1 and PRSS15 (protease, serine, 15). Browse Assay Genie's current range of LONP1 research reagents below, or read on for the biology behind the target.
LONP1 is an ATP-dependent serine protease that mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides, as well as certain short-lived regulatory proteins, in the mitochondrial matrix. Reported endogenous substrates include steroidogenic acute regulatory (StAR) protein, DELE1, the helicase Twinkle (TWNK) and the large ribosomal subunit protein MRPL32/bL32m. MRPL32/bL32m is protected from degradation by LONP1 when bound to RNA, whereas TWNK is not.
Beyond proteolysis, LONP1 has an ATP-dependent chaperone activity and functions in mitochondrial protein folding. It may also act in the assembly of inner membrane protein complexes. The protein takes part in regulating mitochondrial gene expression and in maintaining the integrity of the mitochondrial genome. It binds mitochondrial promoters and RNA in a single-stranded, site-specific and strand-specific manner, and may regulate mitochondrial DNA replication or gene expression by targeting the degradation of regulatory proteins bound at adjacent promoter sites.
The LONP1 gene encodes a member of the Lon family of ATP-dependent proteases, which belongs to the peptidase S16 family. HGNC places it among the AAA ATPases, serine proteases and mitochondrial nucleoid associated proteins. Alternatively spliced transcript variants have been described. Decreased LONP1 expression has been noted in a patient with hereditary spastic paraplegia. Mouse and rat each have a Lonp1 ortholog.
LONP1 removes misfolded, unassembled or oxidatively damaged proteins from the matrix and contributes to protein folding, making it central to mitochondrial quality control.
LONP1 helps maintain mitochondrial genome integrity and binds mitochondrial promoters, so it is studied in mtDNA replication and gene expression.
Substrates such as StAR, DELE1, TWNK and MRPL32/bL32m allow investigation of how LONP1 selects short-lived regulatory proteins for degradation.
Decreased LONP1 expression has been noted in a patient with hereditary spastic paraplegia, prompting interest in its role in neurological disorders.
LONP1 is an ATP-dependent serine protease in the mitochondrial matrix. It degrades misfolded, unassembled or oxidatively damaged proteins and some short-lived regulatory proteins. It also has ATP-dependent chaperone activity and contributes to mitochondrial gene expression and genome integrity.
LONP1 (lon peptidase 1, mitochondrial) is also called Lon protease homolog, mitochondrial, LonHS, hLON, PIM1 and PRSS15. The previous HGNC name was protease, serine, 15. Alternatively spliced transcript variants of the gene have been reported.
Mouse and rat both have a Lonp1 ortholog. Decreased LONP1 expression has been noted in a patient with hereditary spastic paraplegia. For antibody or ELISA work, check the datasheet of any product for its validated reactivity.
Other mitochondrial proteases, AAA ATPases and mitochondrial quality-control proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P36776; product specifications from Assay Genie datasheets.